Janux CMO Departs, Company Assures No Change to Development Plans
Reported by Wiseek News
Sentiment
Neutral
Importance
7
Price
$14.84
Mkt Cap
$909.277M
52W Low
$12.12
52W High
$35.34
Market data snapshot near publication time
Summary
Janux Therapeutics announced the departure of its Chief Medical Officer, William Go, effective June 23, 2026. This news follows an 8-K filing on the same day. While the departure of a CMO is a significant event for a biotech company, Janux stated it was a termination without cause, not due to disagreements, and that clinical development plans and timelines remain unchanged. The company has initiated a search for a successor.
At the time of this announcement, JANX was trading at $14.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $909.3M. The 52-week trading range was $12.12 to $35.34. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.
Price Chart
JANX - Latest Insights
JANX
Jun 23, 2026, 4:13 PM EDT
Price at Filing:
$14.84
Real-time Price:
$14.84
Change:
$0 (0%)
Market Cap:
$909.277M
JANX
Jun 23, 2026, 4:05 PM EDT
Price at Filing:
$14.91
Real-time Price:
$14.84
Change:
-$0.070 (-0.47%)
Market Cap:
$909.277M
JANX
May 07, 2026, 4:50 PM EDT
Price at Filing:
$14.54
Real-time Price:
$14.84
Change:
+$0.300 (+2%)
Market Cap:
$909.277M
JANX
May 07, 2026, 4:33 PM EDT
Price at Filing:
$14.54
Real-time Price:
$14.84
Change:
+$0.300 (+2%)
Market Cap:
$909.277M
JANX
May 07, 2026, 4:16 PM EDT
Price at Filing:
$14.54
Real-time Price:
$14.84
Change:
+$0.300 (+2%)
Market Cap:
$909.277M
JANX
Feb 26, 2026, 4:32 PM EST
Price at Filing:
$13.56
Real-time Price:
$14.84
Change:
+$1.28 (+9%)
Market Cap:
$909.277M
JANX
Feb 26, 2026, 4:10 PM EST
Price at Filing:
$13.70
Real-time Price:
$14.84
Change:
+$1.14 (+8%)
Market Cap:
$909.277M
JANX
Jan 22, 2026, 4:30 PM EST
Price at Filing:
$15.04
Real-time Price:
$14.84
Change:
-$0.200 (-1%)
Market Cap:
$909.277M